FDA Inspection 1241162 — Khalid Sharif, MD
The FDA completed an inspection of Khalid Sharif, MD on Jun 5, 2024 in Birmingham. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 5, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Birmingham (United Kingdom)
Additional Details
Clinical Investigator (CI)